FDA Inspection 1293724 — BioMylz Pvt. Ltd.
The FDA completed an inspection of BioMylz Pvt. Ltd. on Feb 9, 2026 in Bengaluru. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Feb 9, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)